Clinilabs, Inc., a specialty contract research organization (CRO), is now a Mortara Certified Partner capable of collecting, processing, and transmitting annotated ECG data compliant with ECG Warehouse requirements.
Clinilabs Achieves Mortara Certified Partner Status
New York, NY (July 25, 2008) – Clinilabs, Inc., a specialty contract research organization (CRO), is now a Mortara Certified Partner capable of collecting, processing, and transmitting annotated ECG data compliant with ECG Warehouse requirements. The Clinilabs ECG Core Laboratory and integrated cardiac safety unit provide state-of-the-art facilities in support of ECG intensive and thorough QT (TQT) studies, operating to the standard required for upload of datasets into the FDA’s ECG Warehouse.
With Mortara Certified Partner status, Clinilabs has a competitive advantage in serving sponsors, and is now among the world’s leading vendors of ECG services. Sponsors that choose Clinilabs as their ECG Core Lab are assured of exceptional service and minimal risk of study failure.
“As a Mortara-certified ECG Core Laboratory, Clinilabs is poised to provide sponsors with the same world-class quality in ECG data management that both large pharmaceutical and biotechnology companies have grown accustomed to receiving from us as a core lab in the CNS arena since 2002,” stated Dr. Gary Zammit, Clinilabs’ President and CEO.
Developed in association with the FDA, the Mortara ECG Warehouse offers tools for uploading annotated ECGs with the Agency capable of efficient review, scoring, and warehousing.
About Clinilabs, Inc.
Clinilabs is a specialty contract research organization (CRO) that provides a full portfolio of services to pharmaceutical, biotechnology, and medical device companies involved in the development of central nervous system (CNS) and cardiovascular (CV) therapeutics. The Company also provides early phase services in a wider range of therapeutic areas at its Phase I facility. Established in 2001, Clinilabs has provided services to more than one third of the world’s top 20 pharmaceutical companies, and has been involved in 7 successful New Drug Applications (NDAs) in central nervous system (CNS) and cardiovascular (CV) indications. For more information, please visit www.clinilabs.com.
About Mortara Instrument
Mortara Instrument, Inc, based in Milwaukee, WI, is distinguished in the field of non-invasive cardiology for innovations that are the core of the company’s complete line of ECG products including electrocardiographs, stress exercise systems, Holter systems and data warehousing solutions, and cardiology monitoring systems. The Company’s website is www.mortara.com.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
Vabysmo Shows Significant Vision Improvement for Diabetic Macular Edema in Underrepresented Patients
October 22nd 2024Phase IV ELEVATUM trial results show that one year of treatment with Vabysmo significantly improved vision in underrepresented racial and ethnic groups with diabetic macular edema, supporting the drug's efficacy and safety across diverse populations.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Clesrovimab Shows Significant Reduction in RSV Infections, Hospitalizations in Infants
October 18th 2024Merck's investigational monoclonal antibody, clesrovimab, shows significant efficacy in reducing respiratory syncytial virus-related infections and hospitalizations in infants, with a favorable safety profile.